223 related articles for article (PubMed ID: 36967375)
1. Impact of corticosteroids on the duration of ventilatory support during severe acute exacerbations of chronic obstructive pulmonary disease in patients in the intensive care unit: a study protocol for a multicentre, randomized, placebo-controlled, double-blind trial.
Ferré A; Thille AW; Mekontso-Dessap A; Similowski T; Legriel S; Aegerter P; Demoule A;
Trials; 2023 Mar; 24(1):231. PubMed ID: 36967375
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support.
Alía I; de la Cal MA; Esteban A; Abella A; Ferrer R; Molina FJ; Torres A; Gordo F; Elizalde JJ; de Pablo R; Huete A; Anzueto A
Arch Intern Med; 2011 Nov; 171(21):1939-46. PubMed ID: 22123804
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroids for severe acute exacerbations of chronic obstructive pulmonary disease in intensive care: From the French OUTCOMEREA cohort.
Galerneau LM; Bailly S; Terzi N; Ruckly S; Garrouste-Orgeas M; Cohen Y; Hong Tuan Ha V; Gainnier M; Siami S; Dupuis C; Darmon M; Azoulay E; Forel JM; Sigaud F; Adrie C; Goldgran-Toledano D; Ferré A; de Montmollin E; Argaud L; Reignier J; Pepin JL; Timsit JF;
PLoS One; 2023; 18(4):e0284591. PubMed ID: 37075003
[TBL] [Abstract][Full Text] [Related]
5. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.
Walters JA; Tan DJ; White CJ; Wood-Baker R
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD006897. PubMed ID: 29553157
[TBL] [Abstract][Full Text] [Related]
6. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal carbon dioxide removal for treatment of exacerbated chronic obstructive pulmonary disease (ORION): study protocol for a randomised controlled trial.
Tonetti T; Pisani L; Cavalli I; Vega ML; Maietti E; Filippini C; Nava S; Ranieri VM
Trials; 2021 Oct; 22(1):718. PubMed ID: 34666820
[TBL] [Abstract][Full Text] [Related]
8. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
[TBL] [Abstract][Full Text] [Related]
9. Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials.
Sivapalan P; Rutishauser J; Ulrik CS; Leuppi JD; Pedersen L; Mueller B; Eklöf J; Biering-Sørensen T; Gottlieb V; Armbruster K; Janner J; Moberg M; Lapperre TS; Nielsen TL; Browatzki A; Mathioudakis A; Vestbo J; Schüetz P; Jensen JU
Respir Res; 2021 May; 22(1):155. PubMed ID: 34020641
[TBL] [Abstract][Full Text] [Related]
10. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.
Walters JA; Tan DJ; White CJ; Wood-Baker R
Cochrane Database Syst Rev; 2014 Dec; (12):CD006897. PubMed ID: 25491891
[TBL] [Abstract][Full Text] [Related]
11. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Vollenweider DJ; Frei A; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010257. PubMed ID: 30371937
[TBL] [Abstract][Full Text] [Related]
12. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
[TBL] [Abstract][Full Text] [Related]
13. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
[TBL] [Abstract][Full Text] [Related]
14. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
15. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
[TBL] [Abstract][Full Text] [Related]
16. Effect of Acetazolamide vs Placebo on Duration of Invasive Mechanical Ventilation Among Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.
Faisy C; Meziani F; Planquette B; Clavel M; Gacouin A; Bornstain C; Schneider F; Duguet A; Gibot S; Lerolle N; Ricard JD; Sanchez O; Djibre M; Ricome JL; Rabbat A; Heming N; Urien S; Esvan M; Katsahian S;
JAMA; 2016 Feb; 315(5):480-8. PubMed ID: 26836730
[TBL] [Abstract][Full Text] [Related]
17. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
18. Acute respiratory failure requiring mechanical ventilation in severe chronic obstructive pulmonary disease (COPD).
Gadre SK; Duggal A; Mireles-Cabodevila E; Krishnan S; Wang XF; Zell K; Guzman J
Medicine (Baltimore); 2018 Apr; 97(17):e0487. PubMed ID: 29703009
[TBL] [Abstract][Full Text] [Related]
19. [Management of acute exacerbations of COPD].
Rabbat A; Guetta A; Lorut C; Lefebvre A; Roche N; Huchon G
Rev Mal Respir; 2010 Oct; 27(8):939-53. PubMed ID: 20965408
[TBL] [Abstract][Full Text] [Related]
20. Multicentre double-blind randomised controlled trial of systematic corticosteroid therapy in patients with acute exacerbations of chronic obstructive pulmonary disease admitted to hospital with higher eosinophil levels: the ECHO protocol.
Liang L; Lin Y; Feng L; Shao S; Cao S; Rong H; Chu S; Xie W; Cai S; Wang J; Tong Z
BMJ Open; 2023 May; 13(5):e066354. PubMed ID: 37247957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
